Global Diabetic Retinopathy Market PowerPoint PPT Presentations

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Diabetic Retinopathy - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Diabetic Retinopathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. For more information on the research report, visit https://www.kenresearch.com/healthcare/pharmaceuticals/diabetic-retinopathy-pipeline-review-h1-2018/149560-91.html

Market Size - $6.5 Billion in 2015, Market Growth - CAGR of 6.9%, Market Trends –Availability of better drug molecules for the treatment

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Read more details at: http://www.bigmarketresearch.com/global-diabetic-retinopathy-2015-2019-market

The research team projects that the Diabetic Retinopathy Treatment market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

Diabetic Retinopathy Market focuses on the global Diabetic Retinopathy status, future forecast, growth opportunity, key market and key players

Global proliferative diabetic retinopathy (pdr) market size is expected at 3.62 Bn by 2028 at a growth rate of 10.6% and growth analysis by The Business Research Company.

The global diabetic socks market size was USD 344.80 Million in 2021 and is expected to register a revenue CAGR of 4.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of diabetics and related complications such as Diabetic Food Ulcer (DFC) and diabetic neuropathy, growing consumer demand for better & improved accessibility and benefits offered by diabetic socks to patients over regular socks, and introduction of innovative smart sock technology are factors driving market revenue growth.

Diabetic macular edema treatment market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 3.65% in the above mentioned forecast period and would likely to reach an estimated value of 63.33 million by 2029 https://www.databridgemarketresearch.com/reports/global-diabetic-macular-edema-treatment-market

Diabetic Retinopathy Market Size By Type, By Management, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

Get more information @ http://bit.ly/2kq4uSV Some of the key players in the diabetic retinopathy market include Bayer, Valeant Pharmaceutical, Novartis, F. Hoffmann-La Roche, Alimera Science, Abbott Laboratories, Pfizer, Regeneron Pharmaceutical, and Ampio Pharmaceuticals. Other notable players include Actavis, Boehringer Ingelheim, Kowa group, BCN peptides, ThromboGenics, Bausch & Lomb, iCo Therapeutics, Quark Pharmaceuticals and Vitreoretinal Technologies among others.

Download Sample Brochure @ http://bit.ly/2e9aeL8 DelveInsight’s Diabetic retinopathy - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and global market trends of the %Indication"% for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Diabetic retinopathy forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Diabetic retinopathy till 2020. Read Analysis @ http://bit.ly/2dRoh9m

Get more information @ http://bit.ly/2kq4uSV North America is predicted to contribute maximum revenue share in access of $4 billion by end of forecast timeframe. Growing access to anti-VEGF items like lucentis, eyelea and avastin along with growing consciousness for early diagnosis to avoid further blindness related with diabetes are the factors predicted to drive the industry demand in the region.

iGATE Research has released a research report on “Global Retinal Surgery Devices Market (By Devices Segment, Application, Geography, Region and Company Profile) – Global Forecast to 2025” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=132 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

The physiotherapy equipment market is estimated to grow at a CAGR of 6.8%to reach $19,786.3 million by 2019.Electric stimulation is the largest segment of the market. However, musculoskeletal will be the fastest-growing application segment during the forecast period. See Full Report @ bit.ly/1uVqa9w

The global diabetic retinopathy market accounted for over USD 6,810 million in 2017 and is expected to grow at a CAGR of 8.7% during the forecast period, 2019–2026.

The vascular endothelial growth factor (VEGF) inhibitor market size is expected to see strong growth in the next few years. It will grow to $13.98 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%.

The global ocular drug delivery market size valued at $67.7 billion in 2022, and is projected to reach $115.5 billion by 2032, growing at a CAGR of 5.5% from 2023 to 2032. The ocular drug delivery market growth is driven by advancement in ocular drug delivery technology, surge in ageing population, and rise in awareness about the various eye disorders. Aged population increases susceptibility to conditions such as age-related macular degeneration (AMD), cataracts, glaucoma, and diabetic retinopathy. Know More- https://www.alliedmarketresearch.com/ocular-drug-delivery-market

Global Widefield Imaging Systems Market will exhibit a CAGR of around 7.35% for the forecast period of 2022-2028. Widefield imaging systems are used in diagnosing and detecting uveitis, diabetic retinopathy, retinal vascular tumours among others. Widefield imaging systems offer excellent postoperative documentation of retinal surgery. Widefield imaging systems is an imaging technology that relies on illumination with the resulting image being viewed and observed by an observer through the camera. The widefield imaging systems are rapidly being adopted by hospitals, clinics, and ambulatory surgery centres. Get Full Access of Report @ https://www.databridgemarketresearch.com/reports/global-widefield-imaging-systems-market

The global retinal imaging devices market is growing at a CAGR of 5.93% and is expected to reach $9322.89 million, during the forecast period of 2023-2032.

iGATE Research has released a research report on “Global Retinal Surgery Devices Market (By Devices Segment, Application, Geography, Region and Company Profile) – Forecast to 2026” Click here to view the complete report: https://www.igateresearch.com/global-retinal-surgery-devices-market-by-devices-segment-application-geography-region-and-company-profile-forecast-to-2026.html Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

Global eye health supplements market size is expected at $2.72 Bn by 2027 at a growth rate of 7.6% and share analysis by The Business Research Company.

This report offers an analysis of the market based on product (reusable ophthalmic knives and single-use ophthalmic knives). The ophthalmic knives market research report further presents an in-depth insight on the growth prospects of the market across Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including Bausch Health, Diamatrix Ltd., HAI Laboratories, Inc., MANI, INC., Novartis AG, and Sidapharm.

This report offers an analysis of the market based on product (reusable ophthalmic knives and single-use ophthalmic knives). The ophthalmic knives market research report further presents an in-depth insight on the growth prospects of the market across Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including Bausch Health, Diamatrix Ltd., HAI Laboratories, Inc., MANI, INC., Novartis AG, and Sidapharm.

The global ophthalmic devices market was valued around $31 billion in 2017. USA was the largest market accounting for around 22% of the total market. Read More: https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-market-global-briefing-2018

North America was the largest region in the ophthalmology drugs market in 2017, accounting for around 31% of the total market. Read Report https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-global-market-report-2018

Global Optical Coherence Tomography (OCT) market Information, by types (Time Domain, Fourier Domain) by Techniques (Adaptive Optics OCT, Polarization-Sensitive OCT, Doppler OCT) Applications (Diabetic retinopathy, eyes imaging) - Forecast to 2027

Looking forward, the ophthalmic lasers market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/ophthalmic-lasers-market

Global Retinal Detachment treatment market Information, by retinal detachment type (Rhegmatogenous, Tractional, Exudative) by applications (Laser surgery, Pneumatic retinopexy, Scleral buckle, Vitrectomy) - Forecast to 2022

Get more information about the market: https://www.imarcgroup.com/vision-care-market According to IMARC Group’s latest report, titled “Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the global vision care market reached a value of US$ 54 Billion in 2017. Request a sample report: https://www.imarcgroup.com/request?type=report&id=846&flag=B Browse more reports on Healthcare industry: http://www.imarcgroup.com/categories/healthcare-market-research-reports contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Follow us on twitter: @imarcglobal

The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. See Full Report : http://bit.ly/1c4gocE

Global Ophthalmology Drugs & Devices Market is expected to reach USD 36.95. billion by 2025, from USD 27.52 billion in 2017 growing at a CAGR of 4.3% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Medical Wide field Imaging Systems Market, by Component (Instruments, Software), Modality (Standalone, Portable), End-User (Specialty Clinics, Hospitals, Ambulatory Surgical Centers) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

Request Sample PDF of report @ http://www.marketintelreports.com/pdfdownload.php?id=gdme0179epd A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2016 Market and future opportunities are provided in the report.

Fundus Cameras Market By Product Type (Mydriatic Fundus Cameras, Tabletop, Handheld, Non-mydriatic Fundus Cameras, Tabletop, Handheld, Hybrid Fundus Cameras, ROP Fundus Cameras) By End-User (Hospitals, Ophthalmology Clinics, Others) By Distribution Channel (Online Store, Offline Store) and Region - Global Forecast 2016 to 2024.

The Global Retinal Disease Therapeutics Market is likely to expand at an impressive rate driven by recent government participation towards the prevention and control of retinal diseases

New Market Research Reports Title Optical Coherence Tomography Market " Has Been Added to Adroit Market Research into reports database.

The study segments the diabetic retinopathy industry in light of major classification such as product type, potential markets, application, and end-user.

Ocular Drug Delivery Technology Market report categorize the global market by Technology (Topical, Ocular Inserts, Iontophoresis, Intraocular Implants and In Situ Gel & Punctal Plugs), Disease Type (Glaucoma, Diabetic Retinopathy, Macular Degeneration), End User & Geography

Globally, the ophthalmic devices market is witnessing significant growth due to increasing prevalence of eye disorders, such as diabetic retinopathy and macular degeneration. In addition, growing global aging population, increasing government initiatives towards healthcare infrastructure in developing countries, and increasing incidence of lifestyle-associated diseases are also driving the growth of the market.

The study segments diabetic retinopathy industry in light of major classification such as product type, potential markets, application, and end-user.

The rising incidences of colorectal cancer, chronic pain, cardiovascular diseases and diabetic retinopathy and unwanted pregnancies globally are expected to drive the implantable drug delivery devices market.

The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors.

The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors.

According to Our Research analysis Ophthalmic Device Market is expected to be US$ 67 Billion by the end of the year 2026. This growth is due to rise in the adoption of digital devices such as laptops, smartphones, tablets, computers, game consoles, television, and e-reader as well as rapid urbanization. Another factor is growing geriatric population globally and a rise in the incidence of chronic eye conditions as a consequence of unhealthy lifestyle results in diabetic retinopathy. Moreover, high stress is also an added reason for the growth in the ophthalmic device market. Follow the Link for More Information: https://www.renub.com/global-ophthalmic-devices-market-nd.php

Market Size – USD 7.39 billion in 2018, Market Growth – CAGR of 7.3%, Market Trends – Product Launches and Research for Advanced Tech Developments

The report examines and analyzes innovation in global parkinsons disease market in the context of the overall pipeline and current market landscape. It provides a brief introduction to parkinson's disease pathophysiology including symptoms and an overview of pharmacotherapy. Browse full report @ http://bit.ly/14ZURze

Ophthalmoscopes Market

According to the latest research report by IMARC Group, The global eye health supplements market size is projected to exhibit a growth rate (CAGR) of 5.4% during 2024-2032. More Info:- https://www.imarcgroup.com/eye-health-supplements-market

Global eylea market size is expected to reach $10.16 Bn by 2028 at a rate of 5.5%, segmented as by product, prefilled syringe package, vial package

According to the latest research report by IMARC Group, The global ophthalmic devices market size reached US$ 27.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. More Info:- https://www.imarcgroup.com/ophthalmic-devices-market

Global retinal disorder treatment market size is expected at $16.42 Bn by 2027, at a growth rate of 9.1% and growth analysis by The Business Research Company.

According to the latest research report by IMARC Group, The global vision care market size reached US$ 71.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 93.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3% during 2024-2032. More Info:- https://www.imarcgroup.com/vision-care-market

The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan).

The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan).

According to the latest research report by IMARC Group, The global eye health supplements market is expected to exhibit a growth rate (CAGR) of 6% during 2023-2028. More Info:- https://www.imarcgroup.com/eye-health-supplements-market

According to the latest study on “Vision Care Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, and Distribution Channel,” the market was valued at US$ 66,934.51 million in 2019 and is projected to reach US$ 93,817.82 million by 2027; it is expected to grow at a CAGR of 4.5% during 2020–2027. The report highlights the trends prevailing in the global vision care market, and drivers and deterrents pertaining to the market growth.